1887

Abstract

The enterovirus 2B protein contains a putative amphipathic α-helix that includes three positively charged and one negatively charged residue. Previously, we observed that replacement of the glutamic acid-40 residue with a lysine residue (mutation 2B-E[40]K) in the amphipathic α-helix of the coxsackie B3 virus 2B protein resulted in a quasi-infectious phenotype. On one occasion, however, transfection of 2B-E[40]K RNA transcripts gave rise to a virus stock in which the mutation was retained. This study was aimed at elucidating the molecular mechanism underlying this observation. Sequence analysis of the viral RNA provided no evidence for a second-site suppression mutation that rescued the defect of the 2B-E[40]K mutation in . Therefore, the possibility was considered that the defect caused by the 2B-E[40]K mutation was complemented in by viable revertants that had emerged in the virus population. The transfection-derived virus stock indeed contained a small fraction of (pseudo)revertant viruses, carrying the original glutamic acid-40, threonine-40 or asparagine-40, rather than the introduced lysine-40. Consistent with the idea that the 2B-E[40]K virus is unable to grow without the aid of -acting wild-type(-like) proteins, only the (pseudo)revertant viruses were able to produce individual plaques. Further support for the idea of -rescue was obtained using a genetic complementation assay, which revealed the occurrence of a low level of -complementation of the 2B-E[40]K mutation by wild-type virus. This is the first report that provides evidence that a genetic defect in the enterovirus 2B protein can be complemented in .

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-83-2-341
2002-02-01
2024-05-05
Loading full text...

Full text loading...

/deliver/fulltext/jgv/83/2/0830341a.html?itemId=/content/journal/jgv/10.1099/0022-1317-83-2-341&mimeType=html&fmt=ahah

References

  1. Aldabe A., Barco A., Carrasco L. 1996; Membrane permeabilization by poliovirus proteins 2B and 2BC. Journal of Biological Chemistry 271:23134–23137
    [Google Scholar]
  2. Barco A., Carrasco L. 1995; A human virus protein, poliovirus protein 2BC, induces membrane proliferation and blocks the exocytic pathway in the yeast Saccharomyces cerevisiae . EMBO Journal 14:3349–3364
    [Google Scholar]
  3. Bernheimer A. W., Rudy B. 1986; Interactions between membranes and cytolytic peptides. Biochimica et Biophysica Acta 864:123–141
    [Google Scholar]
  4. Bernstein H. D., Sarnow P., Baltimore D. 1986; Genetic complementation among poliovirus mutants derived from an infectious cDNA clone. Journal of Virology 60:1040–1049
    [Google Scholar]
  5. Bienz K., Egger D., Rasser Y., Bossart W. 1983; Intracellular distribution of poliovirus proteins and the induction of virus-specific cytoplasmic structures. Virology 131:39–48
    [Google Scholar]
  6. Cao X., Wimmer E. 1995; Intragenomic complementation of a 3AB mutant in dicistronic polioviruses. Virology 209:315–326
    [Google Scholar]
  7. Charini W. A., Burns C. C., Ehrenfeld E., Semler B. L. 1991; Trans rescue of a mutant poliovirus RNA polymerase function. Journal of Virology 65:2655–2665
    [Google Scholar]
  8. Cho M. W., Teterina N., Egger D., Bienz K., Ehrenfeld E. 1994; Membrane rearrangement and vesicle induction by recombinant poliovirus 2C and 2BC in human cells. Virology 202:129–145
    [Google Scholar]
  9. Chomczynski P., Sacchi N. 1987; Single step method of RNA isolation by acid guanidium thiocyanate–phenol–chloroform extraction. Analytical Biochemistry 162:156–159
    [Google Scholar]
  10. Collis P. S., O’Donnel B. J., Barton D. J., Rogers J. A., Flanegan J. B. 1992; Replication of poliovirus RNA and subgenomic RNA transcripts in transfected cells. Journal of Virology 66:6480–6488
    [Google Scholar]
  11. Doedens J. R., Kirkegaard K. 1995; Inhibition of cellular protein secretion by poliovirus proteins 2B and 3A. EMBO Journal 14:894–907
    [Google Scholar]
  12. Giachetti C., Hwang S.-S., Semler B. L. 1992; Cis -acting lesions targeted to the hydrophobic domain of a poliovirus membrane protein involved in RNA replication. Journal of Virology 66:6045–6057
    [Google Scholar]
  13. Gmyl A. P., Pilipenko E. V., Maslova S. V., Belov G. A., Agol V. I. 1993; Functional and genetic plasticities of the poliovirus genome: quasi-infectious RNAs modified in the 5′-untranslated region yield a variety of pseudorevertants. Journal of Virology 67:6309–6316
    [Google Scholar]
  14. Johnson K. L., Sarnow P. 1991; Three poliovirus 2B mutants exhibit noncomplementable defects in viral RNA replication and display dosage-dependent dominance over wild-type poliovirus. Journal of Virology 65:4341–4349
    [Google Scholar]
  15. Klump W. M., Bergman I., Muller B. C., Ameis D., Kandolf R. 1990; Complete nucleotide sequence of infectious coxsackievirus B3 cDNA: two initial 5′ uridine residues are regained during plus-strand RNA synthesis. Journal of Virology 64:1573–1583
    [Google Scholar]
  16. Li J.-P., Baltimore D. 1988; Isolation of poliovirus mutants defective in viral RNA synthesis. Journal of Virology 62:4016–4021
    [Google Scholar]
  17. Novak J. E., Kirkegaard K. 1994; Coupling between genome translation and replication in an RNA virus. Genes & Development 8:1726–1737
    [Google Scholar]
  18. Nugent C. I., Johnson K. L., Sarnow P., Kirkegaard K. 1999; Functional coupling between replication and packaging of poliovirus replicon RNA. Journal of Virology 73:427–435
    [Google Scholar]
  19. Reed L. J., Muench H. 1938; A simple method of estimating the fifty per cent endpoints. American Journal of Hygiene 27:493–497
    [Google Scholar]
  20. Sandoval I., Carrasco L. 1997; Poliovirus infection and expression of the poliovirus 2B provoke the disassembly of the Golgi complex, the organelle target for the antipoliovirus drug Ro-090179. Journal of Virology 71:4679–4693
    [Google Scholar]
  21. Segrest J. P., de Loof H., Dohlman J. G., Brouillette C. G., Anantharamaiah G. M. 1990; Amphipathic helix motif: classes and properties. Proteins 8:103–117
    [Google Scholar]
  22. Teterina N. L., Zhou W. D., Cho M. W., Ehrenfeld E. 1995; Inefficient complementation activity of poliovirus 2C and 3D proteins for rescue of lethal mutations. Journal of Virology 69:4245–4254
    [Google Scholar]
  23. Tolskaya E. A., Romanova L. I., Kolesnikova M. S., Gmyl A. P., Gorbalenya A. E., Agol V. I. 1994; Genetic studies on the poliovirus 2C protein, an NTPase. Journal of Molecular Biology 236:1310–1323
    [Google Scholar]
  24. Towner J. S., Mazanet M. M., Semler B. L. 1998; Rescue of defective poliovirus RNA replication by 3AB-containing precursor proteins. Journal of Virology 72:7191–7200
    [Google Scholar]
  25. van Kuppeveld F. J. M., Galama J. M. D., Zoll J., Melchers W. J. G. 1995; Genetic analysis of a hydrophobic domain of coxsackie B3 virus protein 2B; a moderate degree of hydrophobicity is required for a cis -acting function in viral RNA synthesis. Journal of Virology 69:7782–7790
    [Google Scholar]
  26. van Kuppeveld F. J. M., Galama J. M. D., Zoll J., van den Hurk P. J. J. C., Melchers W. J. G. 1996; Coxsackie B3 virus protein 2B contains a cationic amphipathic helix that is required for viral RNA replication. Journal of Virology 70:3876–3886
    [Google Scholar]
  27. van Kuppeveld F. J. M., Hoenderop J. G. J., Smeets R. L. L., Willems P. H. G. M., Dijkman H. B. P. M., Galama J. M. D., Melchers W. J. G. 1997a; Coxsackievirus protein 2B modifies endoplasmic reticulum membrane and plasma membrane permeability and facilitates virus release. EMBO Journal 16:3519–3532
    [Google Scholar]
  28. van Kuppeveld F. J. M., Melchers W. J. G., Kirkegaard K., Doendens J. R. 1997b; Structure-function analysis of coxsackie B3 virus protein 2B. Virology 227:111–118
    [Google Scholar]
  29. Wimmer E., Helen C. U. T., Cao X. 1993; Genetics of poliovirus. Annual Review of Genetics 27:353–436
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-83-2-341
Loading
/content/journal/jgv/10.1099/0022-1317-83-2-341
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error